← All indications
Sarcopenia
Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
Drugs by status
Phase 4 trials (14)
Phase 3 trials (10)
Phase 2 trials (24)
Phase 1 trials (11)
Other trials (67)
- mannitol
- melatonin
- nitroglycerin
- 13c-leucine
- phenylalanine
- astaxanthin
- ibuprofen
- egg
- vitis vinifera
- paclitaxel
- gastric inhibitory polypeptide
- liraglutide
- bovine colostrum
- inulin
- citrulline
- krill oil
- octreotide
- beta-glucans
- peanut
- atorvastatin
- pomegranate
- trastuzumab
- carboplatin
- pertuzumab
- acetylsalicylic acid
- sunflower oil
- conjugated linoleic acid
- resveratrol
- collagen
- cellulose
- +37 more
Organizations
Organization Involved with Phase 4 Indications (16)
- Baxalta
- Bayer
- National Institute on Aging (NIA)
- Boston University
- Federal University of Juiz de Fora
- University of Dundee
- University of Lausanne
- University of Manchester
- University of Bern
- Tel Aviv University
- Leiden University
- Cha Medical University
- Dayanand Medical College
- University of Texas, Galveston
- Erasmus University Rotterdam
- Department of Veteran Affairs
Organization Involved with Phase 3 Indications (14)
- Harvard University
- Gdansk University of Physical Education and Sport
- Johns Hopkins University
- Mahidol University
- University of Maryland
- University of Nottingham
- University of Saskatchewan
- University of Colorado, Denver
- University of Connecticut
- University of Nice Sophia Antipolis
- Washington University in St. Louis
- Gatorade Sports and Science Institute
- Pusan National University
- The University of Texas, Dallas
Organization Involved with Phase 2 Indications (21)
- Regeneron
- Merck
- Sanofi
- Novartis
- Endo Pharmaceuticals
- Immunotec Inc.
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Maastricht University
- Emory University
- University of Washington
- New York Medical College
- University of Southern California
- Wake Forest University
- Vanderbilt University
- University of Regina
- University of Montreal
- University of Texas at Houston
- University of Texas, San Antonio
- Institut Hospital del Mar d'Investigacions Mèdiques
- Biophytis
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (61)
- Edward Via
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- Lesieur
- POM Wonderful LLC
- National Institute of Cardiology, Laranjeiras, Brazil
- National Polytechnic Institute, Mexico
- University of Roma La Sapienza
- University of Manitoba
- Alexandria University
- Brazilian National Cancer Institute
- University of London
- Chimei Medical Center
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Federal University of Health Science of Porto Alegre
- Federal University of Minas Gerais
- Hoosier Cancer Research Network
- Katholieke Universiteit Leuven
- McMaster University
- Medical University of Gdansk
- Rio de Janeiro State University
- Translational Research Institute for Metabolism and Diabetes, Florida
- Universidade Estadual de Londrina
- University of Glasgow
- University of Pavia
- University of Thessaly
- University of Aberdeen
- University of Arkansas
- University of Birmingham
- University of Warwick
- +31 more